Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression.

Abstract

Alterations of the 5-HT1A receptor and BDNF have consistently been associated with affective disorders. Two functional single nucleotide polymorphisms (SNPs), rs6295 of the serotonin 1A receptor gene (HTR1A) and rs6265 of brain-derived neurotrophic factor gene (BDNF), may impact transcriptional regulation and expression of the 5-HT1A receptor. Here we investigated interaction effects of rs6295 and rs6265 on 5-HT1A receptor binding. Forty-six healthy subjects were scanned with PET using the radioligand [carbonyl-11C]WAY-100635. Genotyping was performed for rs6265 and rs6295. Subjects showing a genotype with at least three risk alleles (G of rs6295 or A of rs6265) were compared to control genotypes. Cortical surface binding potential (BPND) was computed for 32 cortical regions of interest (ROI). Mixed model was applied to study main and interaction effects of ROI and genotype. ANOVA was used for post hoc analyses. Individuals with the risk genotypes exhibited an increase in 5-HT1A receptor binding by an average of 17% (mean BPND 3.56 ± 0.74 vs. 2.96 ± 0.88). Mixed model produced an interaction effect of ROI and genotype on BPND and differences could be demonstrated in 10 ROI post hoc. The combination of disadvantageous allelic expression of rs6295 and rs6265 may result in a 5-HT1A receptor profile comparable to affective disorders as increased 5-HT1A receptor binding is a well published phenotype of depression. Thus, epistasis between BDNF and HTR1A may contribute to the multifactorial risk for affective disorders and our results strongly advocate further research on this genetic signature in affective disorders.

• Authors: Alexander Kautzky, Gregory M James, Cecile Philippe, Pia Baldinger-Melich, Christoph Kraus, Georg S Kranz, Thomas Vanicek, Gregor Gryglewski, Annette M Hartmann, Andreas Hahn, Wolfgang Wadsak, Markus Mitterhauser, Dan Rujescu, Siegfried Kasper, Rupert Lanzenberger
• Journal: Translational psychiatry (Transl Psychiatry) Vol. 9 Issue 1 Pg. 5 (01 16 2019) ISSN: 2158-3188 [Electronic] United States
• PMID: 30664620 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Brain-Derived Neurotrophic Factor
• HTR1A protein, human
• Piperazines
• Pyridines
• Receptor, Serotonin, 5-HT1A
• BDNF protein, human
• N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide

Topics

• Adult
• Alleles
• Brain (diagnostic imaging, metabolism)
• Brain-Derived Neurotrophic Factor (genetics, metabolism)
• Cross-Sectional Studies
• Depressive Disorder (genetics)
• Epistasis, Genetic
• Female
• Genotype
• Healthy Volunteers
• Humans
• Male
• Middle Aged
• Piperazines (metabolism)
• Polymorphism, Single Nucleotide
• Positron-Emission Tomography
• Pyridines (metabolism)
• Receptor, Serotonin, 5-HT1A (genetics, metabolism)